NeoGenomics, Inc. ( NEO) - Stock Earnings
NEO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 27, 2026 AfterMarket | — / — | — | — / — | — |
NEO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -9.9 million USD | 190.2 million USD |
| 2026Q1 | -17.1 million USD | 186.7 million USD |
| 2026Q2 | 2.2 million USD | 201.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
NEO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -88.0 million USD | 591.6 million USD |
| 2024 | -78.7 million USD | 660.6 million USD |
| 2025 | -108.0 million USD | 727.3 million USD |
| 2026 Est. | — | — |
NEO
Price: $17.38
Earnings Per Share: -0.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 437800
Ebitda: 2.2 millionMarket Capitalization: 446.6 million